Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-01-08
DOI
10.1038/srep07608
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In Vivo Application of beta Amyloid Oligomers: A Simple Tool to Evaluate Mechanisms of Action and New Therapeutic Approaches
- (2015) Claudia Balducci et al. CURRENT PHARMACEUTICAL DESIGN
- Metabotropic glutamate receptor 5 knockout reduces cognitive impairment and pathogenesis in a mouse model of Alzheimer's disease
- (2014) Alison Hamilton et al. Molecular Brain
- Amyloid β, Glutamate, Excitotoxicity in Alzheimer's Disease: Are We on the Right Track?
- (2013) Zaira Esposito et al. CNS Neuroscience & Therapeutics
- Alzheimer´s Disease and Oxidative Stress: A Review
- (2013) Miroslav Pohanka CURRENT MEDICINAL CHEMISTRY
- Discovering New Treatments for Alzheimer's Disease by Repurposing Approved Medications
- (2013) Brian Appleby et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Successes and Failures for Drugs in Late-Stage Development for Alzheimer’s Disease
- (2013) Camryn Berk et al. DRUGS & AGING
- Glutamate, Glutamate Receptors, and Downstream Signaling Pathways
- (2013) Stacey S. Willard et al. International Journal of Biological Sciences
- Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease
- (2013) Andrea C. Paula-Lima et al. JOURNAL OF NEUROCHEMISTRY
- Operational dissection of β-amyloid cytopathic effects on cultured neurons
- (2013) Noelle Callizot et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Metabotropic Glutamate Receptor 5 Is a Coreceptor for Alzheimer Aβ Oligomer Bound to Cellular Prion Protein
- (2013) Ji Won Um et al. NEURON
- Acamprosate Produces Its Anti-Relapse Effects Via Calcium
- (2013) Rainer Spanagel et al. NEUROPSYCHOPHARMACOLOGY
- Alzheimer's Disease Related Markers, Cellular Toxicity and Behavioral Deficits Induced Six Weeks after Oligomeric Amyloid-β Peptide Injection in Rats
- (2013) Charleine Zussy et al. PLoS One
- Animal Models of Alzheimer Disease
- (2013) F. M. LaFerla et al. Cold Spring Harbor Perspectives in Medicine
- Alzheimer's therapeutics: Continued clinical failures question the validity of the amyloid hypothesis—but what lies beyond?
- (2012) Kevin Mullane et al. BIOCHEMICAL PHARMACOLOGY
- The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer’s disease
- (2012) Pedro M. Pimentel-Coelho et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- The γ-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl)sulfonyl](2,5-difluorophenyl) amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates Aβ1–42 seeding and short-term memory deficits in the Aβ25–35 mouse model of Alzheimer's disease
- (2012) Johann Meunier et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Glutamate system, amyloid β peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology
- (2012) Timothy Revett et al. JOURNAL OF PSYCHIATRY & NEUROSCIENCE
- Poly(ADP-ribose) Polymerase-1 in Amyloid Beta Toxicity and Alzheimer's Disease
- (2012) Joanna B. Strosznajder et al. MOLECULAR NEUROBIOLOGY
- Mitochondrial Dysfunction—A Pharmacological Target in Alzheimer's Disease
- (2012) Gunter P. Eckert et al. MOLECULAR NEUROBIOLOGY
- Loss of functional GABAA receptors in the Alzheimer diseased brain
- (2012) A. Limon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Time-Course and Regional Analyses of the Physiopathological Changes Induced after Cerebral Injection of an Amyloid β Fragment in Rats
- (2011) Charleine Zussy et al. AMERICAN JOURNAL OF PATHOLOGY
- Behavioural and cellular effects of exogenous amyloid-β peptides in rodents
- (2011) Caroline Chambon et al. BEHAVIOURAL BRAIN RESEARCH
- Networking for new drugs
- (2011) Claire Ainsworth NATURE MEDICINE
- Interaction between NH2-tau fragment and Aβ in Alzheimer's disease mitochondria contributes to the synaptic deterioration
- (2011) Giuseppina Amadoro et al. NEUROBIOLOGY OF AGING
- Oxidative Stress and β-Amyloid Protein in Alzheimer’s Disease
- (2011) Zhiyou Cai et al. NEUROMOLECULAR MEDICINE
- Hippocampal synaptic plasticity in Alzheimer’s disease: what have we learned so far from transgenic models?
- (2011) Cristina Marchetti et al. REVIEWS IN THE NEUROSCIENCES
- The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia
- (2010) Costantino Iadecola ACTA NEUROPATHOLOGICA
- Neuroinflammatory processes in Alzheimer’s disease
- (2010) Michael T. Heneka et al. JOURNAL OF NEURAL TRANSMISSION
- Group II Metabotropic Glutamate Receptor Stimulation Triggers Production and Release of Alzheimer's Amyloid 42 from Isolated Intact Nerve Terminals
- (2010) S. H. Kim et al. JOURNAL OF NEUROSCIENCE
- GABAB Receptor Activation Protects Neurons from Apoptosis via IGF-1 Receptor Transactivation
- (2010) H. Tu et al. JOURNAL OF NEUROSCIENCE
- Why Pleiotropic Interventions are Needed for Alzheimer's Disease
- (2010) Sally A. Frautschy et al. MOLECULAR NEUROBIOLOGY
- Targeting Group II Metabotropic Glutamate (mGlu) Receptors for the Treatment of Psychosis Associated with Alzheimer's Disease: Selective Activation of mGlu2 Receptors Amplifies -Amyloid Toxicity in Cultured Neurons, Whereas Dual Activation of mGlu2 and mGlu3 Receptors Is Neuroprotective
- (2010) F. Caraci et al. MOLECULAR PHARMACOLOGY
- Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
- (2010) Jorge J Palop et al. NATURE NEUROSCIENCE
- Astrocytes in Alzheimer’s disease
- (2010) Alexei Verkhratsky et al. Neurotherapeutics
- Alzheimer's Disease
- (2010) Henry W. Querfurth et al. NEW ENGLAND JOURNAL OF MEDICINE
- ‘Too much good news’ – are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease?
- (2010) Kathleen R. Zahs et al. TRENDS IN NEUROSCIENCES
- Glycine Receptors Involved in Acamprosateâs Modulation of Accumbal Dopamine Levels: An In Vivo Microdialysis Study
- (2009) PeiPei Chau et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Alzheimer Disease–Associated Peptide, Amyloid β40, Inhibits Vascular Regeneration With Induction of Endothelial Autophagy
- (2009) Shin-ichiro Hayashi et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Subcellular and metabolic examination of amyloid-β peptides in Alzheimer disease pathogenesis: Evidence for Aβ25–35
- (2009) Yury G. Kaminsky et al. EXPERIMENTAL NEUROLOGY
- Glycine and glycine receptor signalling in non-neuronal cells
- (2009) Jimmy Van den Eynden Frontiers in Molecular Neuroscience
- A leaky blood-brain barrier, fibrinogen infiltration and microglial reactivity in inflamed Alzheimer’s disease brain
- (2008) Jae K. Ryu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
- (2008) Berislav V. Zlokovic NEURON
- Antiamnesic and Neuroprotective Effects of the Aminotetrahydrofuran Derivative ANAVEX1-41 Against Amyloid β25–35-Induced Toxicity in Mice
- (2008) Vanessa Villard et al. NEUROPSYCHOPHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started